Epithelial ovarian cancer is the leading cause of cancer deaths from gynecological malignancies. Angiogenesis is considered essential for tumor growth and the development of metastases. VEGF and IL?8 are potent angiostimulatory molecules and their expression has been demonstrated in many solid tumors, including ovarian cancer.VEGF and IL-8 concentrations were measured by ELISA test (HumanVEGF,IL-8). Bioassay ELISA/ US Biological / USA).The median VEGF and IL-8 levels were significantly higher in the sera of ovarian cancer patients than in those with benign tumors and in healthy controls.Pretreatment VEGF and IL-8 serum levels might be regarded as an additional tool in the differentiation of ovarian tumors
Objective: Insight into the expression of multiple vascular endothelial growth factor (VEGF) family ...
AbstractINTRODUCTION: In ovarian cancer, new therapeutic strategies are needed because the vast majo...
Objective: Ovarian cancer is a global problem and is the eighth most common type of cancer in women....
As a promoter of angiogenesis, vascular endothelial growth factor (VEGF) is believed to play a pivot...
OBJECTIVE: To determine the levels of the angiogenic factors vascular endothelial growth factor (VEG...
AbstractElevated serum levels of several cytokines have been reported in ovarian cancer. We have pre...
The progressive growth of epithelial ovarian cancer tumor is regulated by proangiogenic molecules a...
OBJECTIVE: To investigate the relationship between serum vascular endothelial growth factor (VEGF) a...
Epithelial ovarian cancer (EOC) is one of the most lethal gynaecologic malignancies with an increasi...
VEGF-C is regarded as one of the most efficient factors in regulating lymphangiogenesis. The aim of ...
The study aimed to assess the usefulness of the determination of cytokines: IL-8, VEGF and its solub...
As cancer development involves pathological vessel formation, 16 angiogenesis markers were evaluated...
This study examines the role of vascular endothelial growth factor (VEGF) as a therapeutic target in...
Objectives: Angiogenesis is a process that is indispensable in cancer progression. A complex network...
Anti-angiogenic therapies are currently in cancer clinical trials, but to date there are no establis...
Objective: Insight into the expression of multiple vascular endothelial growth factor (VEGF) family ...
AbstractINTRODUCTION: In ovarian cancer, new therapeutic strategies are needed because the vast majo...
Objective: Ovarian cancer is a global problem and is the eighth most common type of cancer in women....
As a promoter of angiogenesis, vascular endothelial growth factor (VEGF) is believed to play a pivot...
OBJECTIVE: To determine the levels of the angiogenic factors vascular endothelial growth factor (VEG...
AbstractElevated serum levels of several cytokines have been reported in ovarian cancer. We have pre...
The progressive growth of epithelial ovarian cancer tumor is regulated by proangiogenic molecules a...
OBJECTIVE: To investigate the relationship between serum vascular endothelial growth factor (VEGF) a...
Epithelial ovarian cancer (EOC) is one of the most lethal gynaecologic malignancies with an increasi...
VEGF-C is regarded as one of the most efficient factors in regulating lymphangiogenesis. The aim of ...
The study aimed to assess the usefulness of the determination of cytokines: IL-8, VEGF and its solub...
As cancer development involves pathological vessel formation, 16 angiogenesis markers were evaluated...
This study examines the role of vascular endothelial growth factor (VEGF) as a therapeutic target in...
Objectives: Angiogenesis is a process that is indispensable in cancer progression. A complex network...
Anti-angiogenic therapies are currently in cancer clinical trials, but to date there are no establis...
Objective: Insight into the expression of multiple vascular endothelial growth factor (VEGF) family ...
AbstractINTRODUCTION: In ovarian cancer, new therapeutic strategies are needed because the vast majo...
Objective: Ovarian cancer is a global problem and is the eighth most common type of cancer in women....